Literature DB >> 9714416

Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.

J P Engvig1, K E Olsen, R E Gislefoss, K Sletten, O Wahlström, P Westermark.   

Abstract

AL-amyloidoses are generally described as a group of disorders in which N-terminal fragments of monoclonal immunoglobulin light chains are transferred into amyloid fibrils. We have, by amino acid sequence analyses and immunological methods, characterized the Bence-Jones protein and the corresponding AL protein as a kappa III immunoglobulin light chain from material of a patient with systemic AL-amyloidosis presenting as a local inguinal tumour. The two proteins showed some unique features. The major part of the AL amyloid fibril protein consisted of C-terminal fragments of the Bence-Jones protein. Furthermore, both the Bence-Jones protein and the AL protein were glycosylated, with possibly a glycosylation in the constant part of the light chain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714416     DOI: 10.1046/j.1365-3083.1998.00352.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

1.  Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains.

Authors:  Lawreen H Connors; Yan Jiang; Marianna Budnik; Roger Théberge; Tatiana Prokaeva; Kip L Bodi; David C Seldin; Catherine E Costello; Martha Skinner
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

2.  A father and his son with systemic AL amyloidosis.

Authors:  Stina Enqvist; Ulf-Henrik Mellqvist; Johan Mölne; Knut Sletten; Charles Murphy; Alan Solomon; Fred J Stevens; Per Westermark
Journal:  Haematologica       Date:  2009-01-27       Impact factor: 9.941

3.  Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain.

Authors:  Yoshinobu Hoshii; Hidemi Nanbara; Dan Cui; Mutsuo Takahashi; Eiji Ikeda
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

4.  Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid.

Authors:  B Häggqvist; J Näslund; K Sletten; G T Westermark; G Mucchiano; L O Tjernberg; C Nordstedt; U Engström; P Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

5.  Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.

Authors:  Batia Kaplan; Brian M Martin; Olga Boykov; Rivka Gal; Mordechai Pras; Itzhak Shechtman; Milton Saute; Mordechai R Kramer
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

6.  Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.

Authors:  Giulia Mazzini; Stefano Ricagno; Serena Caminito; Paola Rognoni; Paolo Milani; Mario Nuvolone; Marco Basset; Andrea Foli; Rosaria Russo; Giampaolo Merlini; Giovanni Palladini; Francesca Lavatelli
Journal:  FEBS J       Date:  2021-09-15       Impact factor: 5.622

7.  The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.

Authors:  Gareth J Morgan; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2016-08-26       Impact factor: 5.469

8.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

9.  Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis.

Authors:  Stina Enqvist; Knut Sletten; Fred J Stevens; Ulf Hellman; Per Westermark
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

10.  Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.

Authors:  Henrik Karring; Ebbe Toftgaard Poulsen; Kasper Runager; Ida B Thøgersen; Gordon K Klintworth; Peter Højrup; Jan J Enghild
Journal:  Mol Vis       Date:  2013-04-12       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.